546 people watching now...

69
$
Per Bottle
total:
$179
$69
+ SHIPPING

49
$
Per Bottle
total:
$1074
$294

59
$
Per Bottle
total:
$537
$177






69
$
Per Bottle
total:
$179
$69
+ SHIPPING

49
$
Per Bottle
total:
$1074
$294

59
$
Per Bottle
total:
$537
$177

69
$
Per Bottle
total:
$179
$69
+ SHIPPING

49
$
Per Bottle
total:
$1074
$294

59
$
Per Bottle
total:
$537
$177

1. Marihart S, Harik M, Djavan B. Dutasteride: A review of current data on a novel dual inhibitor of 5-alpha reductase. Reviews in Urology. 2005;7:203–10.
2. Chapple C. Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for practicing clinician. BJU International. 2004;94(5 Suppl):–.
3. Jemal A, Fedewa S, Ma J, Siegel R, Lin C, Brawley O, Ward E. Prostate cancer incidence and PSA testing in relation to USPSTF screening recommendations. Journal of the American Medical Association. 2015;314(19):2054–2061.
4. Kirby RS. Fast Facts: Prostate Cancer. 10th edition. Karger; 2020.
5. Kamyar Ghabili, Jeffrey J. Tosoian, Edward M. Schaeffer et al. The History of Prostate Cancer From Antiquity: Review of Paleopathological Studies. Urology. November 2016.
6. McConnell JD, Barry MJ, Bruskewitz RC, et al. Benign prostatic hyperplasia: diagnosis and treatment. Clinical Practice Guideline, No. 8. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services; 1994.
7. Barry MJ, Cockett AT, Holtgrewe HL, et al. Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. Journal of Urology. 1993;150:351–58.
8 Wilm T, Ishani A, MacDonald R, et al. Pygeum africanum for benign prostatic hyperplasia (Cochrane Review). The Cochrane Library, Issue 2. Chichester, UK: John Wiley & Sons, Ltd; 2005.
9. Wilt T, Reda D, Bruskewitz R, et al. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. New England Journal of Medicine. 1995;332:75–79.
10. Djavan B, Remzi M, Erne B, Marberger M. The pathophysiology of benign prostatic hyperplasia. Drugs Today. 2002;38:867–70.
Terms & Conditions
Privacy Policy
Returns
Disclaimer
Contact
Statements on this website have not been evaluated by the Food and Drug Administration. Products are not intended to diagnose, treat, cure or prevent any disease.
The website's content and the product for sale is based upon the author's opinion and is provided solely on an "AS IS" and "AS AVAILABLE" basis. You should do your own research and confirm the information with other sources when searching for information regarding health issues and always review the information carefully with your professional health care provider before using any of the protocols presented on this website and/or in the product sold here. Neither BuyGoods nor the author are engaged in rendering medical or similar professional services or advice via this website or in the product, and the information provided is not intended to replace medical advice offered by a physician or other licensed healthcare provider. You should not construe BuyGoods's sale of this product as an endorsement by BuyGoods of the views expressed herein, or any warranty or guarantee of any strategy, recommendation, treatment, action, or application of advice made by the author of the product.
Some names and personal identifying information on this site have been changed to protect the privacy of individuals.
© Protaste Max Research 2025. All Rights Reserved.